type full_text Care Plan <DSC>TCU OPS to monitor LFT KIV restart rosuvastatin and valproate with Memo (to indicate the usual dose of valproate and rosuvastatin) Old TCUs 14/5/24 CGH for psychological medication Clinical Summary Khoo/ 83 yo Chinese FemaleNKDABaseline ADL assisted by son Ambulates with WS at home 1 person assistLives with youngest son (main caregiver)Spend daytime at day care Past medical history 1. HTN HLD 2. AF on apixaban 2.5 mg BD TTE (Nov 2021): LVEF 55 60 , no RWMA, Intermediate echocardiographic probability of pulmonary hypertension. PASP 42 mmHg 3. Non DM nephropathy (previous HbA1c normal) last baseline Cr 754. Thalassemia 5. Osteoporosis BMD 2021: Osteopenia but has history of L 2 compression fracture 6. Mixed Dementia 7. Recurrent falls 8. Incidental finding of stable small ?meningioma 9. b/g previous ischemic stroke May 202310. Admission to SGH 25/6 12/7/23 i. Tokyo grade 2 cholangitis secondary to gallstone CXR (25/06/23): clear no consolidation or pleural effusion UFEME 125/43/0, urine c/s NBG blood c/s (25/6) NBG US Abdo 27/6: Multiple gallstones. Mildly dilated CBD (0.8 cm). Calculi in distal CBD. r/v by GAS (27/6): offered ERCP, however family declined Completed 9 days of IV Roc/Flagyl (25/06 03/07)Complicated by: 1 A. Borderline BP fluid responsive 1 B. AMS likely hypoactive delirium 1 C. KDIGO 1 AKI baseline Cr 75, 141 at ED Improved with IV Hydration ii. Acute deconditioning PT/OT reviews for rehab Transferred to SKCH space for SSR (application routed to SKCH on 6/7/23) 11. Admitted Comm Hospital on 12 July to 12 Aug 2023 due to 1. hypoactive delirium (resolved) B/g Mixed dementia on dementia daycare noted to be sleeping more for past 3 days prior to admission as [REDACTED][REDACTED] on admission sleepy, on off waking up able to maintain eye contact urine c/s NBG , bloods unremarkable initially stopped escitalopram and switched to risperidone, but stopped risperidone ivo daytime drowsiness limiting rehab started epllim 300 mg ON nighttime sleep and daytime activity improved with epillim 300 mg ON and mirtazapine 15 mg ON. Kept on discharge. Memo to existing PSY to f/u on discharge Pt is fit for dementia day care as of discharge on 12/8/23.Pt discharged well and stable on 12/8/23 LOS: 32 days. extended as caregiver not available until 12/8/23 HOPC CC: PR bleeding hematuriaAccording to son 16 17 Nov was admitted in Malaysia Gleaneagles due to Pneumonia Liver Infection given Ciprofloxacin discharged improvedInterim follows up with Polyclinic was told there was abnormal blood resultsToday noted patient to have blood in stools and urine At ED son changed diaper > noted fresh blood again denies fever / cough / colds( ) gradual onset of functional declineno headache / dizzinessno chest pain / dyspneadenies abdominal pain / nausea / vomiting / diarrheano urinary symptomsno bipedal edema Subjective S/b Dr SheinUnable to get appropriate history from patient, bg mixed dementia Objective Vitals stable, HR 85, Stable under RAo/eAlert, not in distressSlightly lethargic looking, hydration drynot orientatedLungs clearCVS S 1 S 2 Abdomen SNT, no guardingCalves supple, no edemaDRE: no skin tags, anal tone intact, brown stools on examining finger Initial Investigations in ED FBC Hb 12.5/ TWC 10.48 (Neu predominant)/ PLt 316 RP HCO3 20.8/Cr 105, others NADLFT NADECG: AF, poor tracingCXR 4/2/24 No focal consolidation or pleural effusion. Linear atelectasis in the right lower zone. Impression 1. UTI UFEME 90 RBCs / 2250 WBCs / no epithelial cells or casts urine cultures (5/2/2024): Klebsiella Pneumoniae<s> Ertapenem, Amikacin, Fosfomycin, Nitrofurantoin<r> otherwise pan resistant <i> Augmentin, PipTazo Treated with 1 D PO Augmentin (7/2) before giving 1 dose of PO Fosfomycin (8/2/2024) patient remained well, no urinary symptoms and afebrile Complicated by 1 a. Hypoglycaemia ?poor oral intake (resolve), ischaemic liver injury (see 1 c.)1 b. AKI with HAGMA from poor intake (resolved) Cr 126 OA (baseline 100 s) > 121 > 108 Bicarb 17.4 OA > 19.8 NAGMA AG 15.2 DR 0.8 Ketone 0 Lactate 1.5 1 c. Deranged LFTs, possibly secondary to ischaemic injury (improving) Presented with shivers, tactile fever, hypoglycaemia b/g prev Tokyo grade 2 cholangitis secondary to gallstone for conservative management in Jun 2023, Cholelithiasis and choledocholithiasis hepatitis B/C screen negative US HBS (6/2/24): Multiple gallstones are identified with abnormal gallbladder wall thickening (5 mm), consistent with cholelithiasis with cholecystitis. In addition, there are echogenic foci seen in the CBD, measuring 7 and 6 mm, likely biliary stones. The common duct measures 13.0 mm. initially covered with IV Ceftriaxone and Metronidazole while awaiting GS review s/b GS, impression of choledocholithiasis, suggest no need for antibiotics in view of no clinical signs of cholecystitis (no abdo pain, afebrile, inflammatory markers flat) Patient was discharged well and stable on 9/2/24 EOC DNR Maxward <Med Changes> Suspended Rosuvastatin and Valproate ivo deranged LFTs Increased Keppra to 500 mg BD